Nuveen Closes on $1.3 Billion in C-PACE Vehicles over 12 Months
Meeting Insurers' Appetite for Clean Energy Assets and Financing Energy Efficiency and Sustainability Projects for Commercial Real Estate
Following the
Seeking Participation in Low-Carbon Energy Transition
In Nuveen's recent survey of major global institutional investors, more than eight in 10 (84%) insurers said they are now considering or planning to consider the low-carbon energy transition in their investment decisions. More than half (53%) of insurers say that, as asset owners, they can significantly influence the energy transition's progress with their capital allocations. When it comes to factors influencing their energy transition investments, 46% of insurers cite enhancing investment returns and 42% indicate portfolio risk management as a top consideration.
"Insurers continue to search for return enhancing investments within their fixed income portfolios, and C-PACE typically offers higher returns than comparable asset classes such as similarly rated commercial mortgage-backed securities or corporate bonds," said
C-PACE Assets a Valued Allocation for Insurers
Nuveen Green Capital is a dominant C-PACE player, responsible for nearly 30 percent of historic market originations, which totaled
"C-PACE has scaled into a sought-after component of insurers' allocations, delivering notable performance, diversity and impact benefits to its investors," said
"At the same time, by facilitating the implementation of renewable energy systems and energy-efficient technologies, C-PACE programs are significantly contributing to reductions in carbon emissions and progress toward climate change mitigation goals," she said.
NGC estimates that its projects have saved 2.64 million megawatt hours of energy and reduced the equivalent of 1.9 million metric tons of carbon, with the carbon reduction impact of 174 square miles of forest over 20 years -- while also saving
Media Contact
E-Soo Kim | [email protected] | 551.224.4919
About Nuveen
Nuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has
Important information on risk
Past performance is no guarantee of future results. All investments carry a certain degree of risk, including the possible loss of principal, and there is no assurance that an investment will provide positive performance over any period of time. Certain products and services may not be available to all entities or persons. There is no guarantee that investment objectives will be achieved.
C-PACE assets are subject to various risks, including but not limited to: risks of insufficient cash flow of the subject property due to impaired operations or value; risks of a decline in the real estate market or financial conditions of a major tenant; risks of delinquencies and defaults; failure of the subject properties to complete agreed upon construction, repairs or improvements or achieve projected energy savings; limited operating history of certain subject properties; risk of assessments underlying certain C-PACE assets failing to comply with applicable state or local laws; risks of disputes with subject property owners and mortgage lenders; environmental contamination risks affecting the subject property; lack of industry-wide prepayment information available for commercial C-PACE assessments; and changes in laws and policies impacting C-PACE programs.
Responsible investing incorporates Environmental Social Governance (ESG) factors that may affect exposure to issuers, sectors, industries, limiting the type and number of investment opportunities available, which could result in excluding investments that perform well.
This fund is only available to accredited investors.
1 C-PACE is a
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuveen-closes-on-1-3-billion-in-c-pace-vehicles-over-12-months-302164071.html
SOURCE Nuveen
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026
- 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
- 2026 World Robot Conference: Zoomlion Showcases Industrial Embodied Intelligence
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share